AstraZeneca PLC (AZNN) — Cash Flow-to-Debt Ratio
AstraZeneca PLC (AZNN) has a Cash Flow-to-Debt Ratio of 0.04x as of December 2025, meaning its operating cash flow of MX$2.34 Billion could theoretically repay 0% of its total liabilities (MX$65.36 Billion) in one year. See AZNN free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
AstraZeneca PLC Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for AstraZeneca PLC across 12 annual periods. Also explore how fast is AstraZeneca PLC growing its equity to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for AstraZeneca PLC (2014–2025)
Year-by-year debt coverage analysis for AstraZeneca PLC. For market capitalisation and broader financial context, see AZNN market cap.
| Year | CF-to-Debt Ratio | Operating CF (MXN) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.22x | MX$14.57 Billion | MX$65.36 Billion | ▲ +18.8% |
| 2024 | 0.19x | MX$11.86 Billion | MX$63.16 Billion | ▲ +12.3% |
| 2023 | 0.17x | MX$10.36 Billion | MX$61.95 Billion | ▲ +1.3% |
| 2022 | 0.17x | MX$9.81 Billion | MX$59.42 Billion | ▲ +82.9% |
| 2021 | 0.09x | MX$5.96 Billion | MX$66.08 Billion | ▼ -3.9% |
| 2020 | 0.09x | MX$4.80 Billion | MX$51.09 Billion | ▲ +48.0% |
| 2019 | 0.06x | MX$2.97 Billion | MX$46.78 Billion | ▲ +13.0% |
| 2018 | 0.06x | MX$2.62 Billion | MX$46.61 Billion | ▼ -26.7% |
| 2017 | 0.08x | MX$3.58 Billion | MX$46.71 Billion | ▼ -15.3% |
| 2016 | 0.09x | MX$4.14 Billion | MX$45.86 Billion | ▲ +13.0% |
| 2015 | 0.08x | MX$3.32 Billion | MX$41.55 Billion | ▼ -55.8% |
| 2014 | 0.18x | MX$7.06 Billion | MX$38.95 Billion | — |